Supporting investment into the region and companies to find funding opportunities

Open funding calls

Manufacturing readiness and scale up of genomic analysis technologies

Innovate UK, as part of UK Research and Innovation, will invest up to £5 million in innovation projects. This is to increase the UK commercial capacity to manufacture real time or rapid genomic analysis equipment such as high throughput nucleic acid sequencing.

A business must lead and can carry out the project on their own or in collaboration with others (businesses, research organisations, Catapults, or academia).

The investment will be funded under the government’s Industrial Strategy Challenge Fund (ISCF) from data to early diagnostics and precision medicine.

To lead a project you must:

  • be a UK based business of any size
  • carry out your project in the UK
  • work alone or in collaboration with others (for example businesses, research base and third sector)
  • have a manufacturing facility for genomic analysis technologies

To be eligible for funding you must:

  • be a UK based business, academic organisation or research and technology organisation (RTO)
  • carry out your project work in the UK
  • intend to exploit the results from or in the UK

The lead organisation must claim funding through this competition. If the project is collaborative, at least one other organisation in the consortium must also claim funding.

For all research organisations, the total level of project participation is set at a maximum of 30% of total eligible project costs.

Any one business may lead on one application and collaborate in a further 2 applications. If a business is not leading an application, they can be a collaborator in up to 3 applications.

An academic institution or RTO cannot lead on an application but can be a collaborator in any number of applications.

More details can be found here

Open date: Monday 18 June 2018
Deadline date: Wednesday 11 July 2018 12:00pm

Creating a network of digital pathology, imaging and AI centres

As part of the delivery of the Industrial Strategy Challenge Fund (ISCF) in data to early diagnosis and precision medicine, Innovate UK, as part of UK Research and Innovation will invest up to £50 million. This is to establish a network of 5 to 6 centres of excellence, across the UK, in digital pathology and/or medical imaging, including radiology. The centres must use digital systems and artificial intelligence (AI) to improve diagnosis and deliver precision treatments.

As radiology and medical imaging is already digitised, bids in this area should look for significant added value from digital systems, enhanced analytics and AI. Applicants may wish to consider the design, development, evaluation and adoption of clinical decision support systems – evaluating, for example, new patient care pathways and providing clinicians with improved tools that will support precision medicine. These elements can also form part of a digital pathology bid (especially in combination with radiology/imaging).

For both digital pathology and imaging/radiology we are looking to fund consortia with a strong industry focus, with a track record of building partnerships and working with companies.

To be eligible for funding you must be:

  • an NHS Trust (or equivalent in the Devolved Administrations)
  • NHS England, NHS Scotland, NHS Wales or Health and Social Care Northern Ireland
  • a hospital
  • an Academic Health Science Network (AHSN)
  • a university or other research organisation
  • a charity
  • a UK based business of any size
  • carry out your programme work in the UK
  • intend to exploit the results for the benefit of the UK

Programmes must be collaborative and at least 2 collaborators must apply for grant.

Further details can be found here

Open date: Wednesday 6 June 2018
Deadline date: Wednesday 1 August 2018 12:00pm

Precision medicine technologies: shaping the future

Innovate UK will invest up to £5 million in innovation projects to support the development of precision medicine (PM) technologies.

Applications can be for either feasibility study projects or industrial research and experimental development projects, although projects may have work packages in different research categories if necessary.

You must explain clearly how your proposed technology will advance precision medicine.

Feasibility study projects: total project costs of up to £100,000 and last up to 12 months. Industrial research and experimental development: total costs up to £2 million and last up to 24 months. Projects must start by 1 November 2018.

Further details can be found here

Open date: Monday 14 May 2018
Deadline date: Wednesday 11 July 2018 12:00pm

OxLEP Innovation Support for Business (ISfB) programme, Phase 2

ISfB Phase 2 is a £5.2m investment supporting Oxfordshire’s innovative entrepreneurs and small and medium sized enterprises (SMEs). We do this by assisting the development and commercialisation of innovative business ideas, as well as enhancing research and innovation infrastructure in Oxfordshire.

Through our latest ISfB programme, we also aim to promote business investment in research and innovation, as well as developing links between businesses and researchers.

We deliver the ISfB programme with partners from the University of OxfordCherwell District CouncilOxford City Council and Oxford University Hospitals NHS Foundation Trust and offer a customisable portfolio of help for eligible entrepreneurs, start-ups and businesses to encourage innovation.

Our support includes:

  • ‘Go-create’ grants
  • Coaching and mentoring
  • Workshops, seminars and master classes
  • Access to equipment, expertise and resources

To find out how we can support you to innovate email [email protected].

SBRI Healthcare: Improving Outcomes in Musculoskeletal Disorders

A new national Small Business Research Initiative (SBRI) Healthcare competition is being launched by NHS England in partnership with the Academic Health Science Networks (AHSNs) to find innovative new products and services. The projects will be selected primarily on their potential value to the health service and on the improved outcomes delivered for patients.

The competition is open to single companies or organisations from the private, public and third sectors, including charities. The competition runs in two phases (subject to availability of budget in 2019):

  • Phase 1 is intended to show the technical feasibility of the proposed concept. The development contracts placed will be for a maximum of 6 months and up to £100,000 (inc. VAT) per project
  • Phase 2 contracts are intended to develop and evaluate prototypes or demonstration units from the more promising technologies in Phase 1. Only those projects that have completed Phase 1 successfully will be eligible for Phase 2.

Developments will be 100% funded and suppliers for each project will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.

Open date: Monday 9 July
Briefing date: Thursday 19 July
Closing date: Wednesday 22 August, noon

SBRI Healthcare: Dentistry, Oral health and Oral Cancers

A new national Small Business Research Initiative (SBRI) Healthcare competition is being launched by NHS England in partnership with the Academic Health Science Networks (AHSNs) to find innovative new products and services. The projects will be selected primarily on their potential value to the health service and on the improved outcomes delivered for patients.

The competition is open to single companies or organisations from the private, public and third sectors, including charities. The competition runs in two phases (subject to availability of budget in 2019):

  • Phase 1 is intended to show the technical feasibility of the proposed concept. The development contracts placed will be for a maximum of 6 months and up to £100,000 (inc. VAT) per project
  • Phase 2 contracts are intended to develop and evaluate prototypes or demonstration units from the more promising technologies in Phase 1. Only those projects that have completed Phase 1 successfully will be eligible for Phase 2.

Developments will be 100% funded and suppliers for each project will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.

Open date: Monday 9 July
Briefing date: Thursday 19 July
Closing date: Wednesday 22 August, noon

Contact: Ashley Aitken

Ashley Aitken
Project Manager, Diagnostics

Ashley has experience of sales and marketing in the life science sector. She is a graduate of the University of Warwick, and specialised in Molecular Genetics.
Email Ashley

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu